Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Both mouse and rat models are effective for testing alopecia areata treatments.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Advanced human skin models improve drug development and could replace animal testing.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

A woman with lupus had blood cell destruction, treated successfully with medication.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Microneedling with Triamcinolone acetonide is an effective, less invasive, and safe alternative to direct injections for treating alopecia areata.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.